Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) (2018)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1177/2047487318777079
- Subjects: ESTATINAS; DOENÇAS CARDIOVASCULARES; COLESTEROL; LIPOPROTEÍNAS LDL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European journal of preventive cardiology
- ISSN: 2047-4873
- Volume/Número/Paginação/Ano: v. 25, n. 10, p. 1087-1094, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DANCHIN, Nicolas e SANTOS, Raul D. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). European journal of preventive cardiology, v. 25, n. 10, p. 1087-1094, 2018Tradução . . Disponível em: https://doi.org/10.1177/2047487318777079. Acesso em: 26 jan. 2026. -
APA
Danchin, N., & Santos, R. D. (2018). Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). European journal of preventive cardiology, 25( 10), 1087-1094. doi:10.1177/2047487318777079 -
NLM
Danchin N, Santos RD. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) [Internet]. European journal of preventive cardiology. 2018 ; 25( 10): 1087-1094.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1177/2047487318777079 -
Vancouver
Danchin N, Santos RD. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) [Internet]. European journal of preventive cardiology. 2018 ; 25( 10): 1087-1094.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1177/2047487318777079 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
Informações sobre o DOI: 10.1177/2047487318777079 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
